These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 22977863)

  • 1. Development of an experimental model of cardiac failure combined with type I diabetes mellitus.
    Afanasiev SA; Kondratyeva DS; Popov SV
    Bull Exp Biol Med; 2012 Aug; 153(4):530-2. PubMed ID: 22977863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral levosimendan prevents postinfarct heart failure and cardiac remodeling in diabetic Goto-Kakizaki rats.
    Louhelainen M; Vahtola E; Forsten H; Merasto S; Kytö V; Finckenberg P; Leskinen H; Kaheinen P; Tikkanen I; Levijoki J; Mervaala E
    J Hypertens; 2009 Oct; 27(10):2094-107. PubMed ID: 19730126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Manifestation of adaptive changes during combined development of postinfarction remodeling of the heart and diabetes mellitus.
    Egorova MV; Afanas'ev SA; Popov SV; Karpov RS
    Bull Exp Biol Med; 2010 Dec; 150(2):172-4. PubMed ID: 21240364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Swim training attenuates myocardial remodeling and the pulmonary congestion in wistar rats with secondary heart failure to myocardial infarction].
    Portes LA; Tucci PJ
    Arq Bras Cardiol; 2006 Jul; 87(1):54-9. PubMed ID: 16906270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HMGB1: the missing link between diabetes mellitus and heart failure.
    Volz HC; Seidel C; Laohachewin D; Kaya Z; Müller OJ; Pleger ST; Lasitschka F; Bianchi ME; Remppis A; Bierhaus A; Katus HA; Andrassy M
    Basic Res Cardiol; 2010 Nov; 105(6):805-20. PubMed ID: 20703492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of glycaemic variability on cardiac remodelling after reperfused myocardial infarction: Evaluation of streptozotocin-induced diabetic Wistar rats using cardiac magnetic resonance imaging.
    Joubert M; Hardouin J; Legallois D; Blanchart K; Elie N; Nowoczyn M; Croisille P; Coulbault L; Bor-Angelier C; Allouche S; Manrique A
    Diabetes Metab; 2016 Nov; 42(5):342-350. PubMed ID: 26971835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deep sea minerals prolong life span of streptozotocin-induced diabetic rats by compensatory augmentation of the IGF-I-survival signaling and inhibition of apoptosis.
    Liao HE; Shibu MA; Kuo WW; Pai PY; Ho TJ; Kuo CH; Lin JY; Wen SY; Viswanadha VP; Huang CY
    Environ Toxicol; 2016 Jul; 31(7):769-81. PubMed ID: 25727812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ginseng reverses established cardiomyocyte hypertrophy and postmyocardial infarction-induced hypertrophy and heart failure.
    Moey M; Gan XT; Huang CX; Rajapurohitam V; Martínez-Abundis E; Lui EM; Karmazyn M
    Circ Heart Fail; 2012 Jul; 5(4):504-14. PubMed ID: 22576957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose and fatty acid metabolism in infarcted heart from streptozotocin-induced diabetic rats after 2 weeks of tissue remodeling.
    Malfitano C; de Souza Junior AL; Carbonaro M; Bolsoni-Lopes A; Figueroa D; de Souza LE; Silva KA; Consolim-Colombo F; Curi R; Irigoyen MC
    Cardiovasc Diabetol; 2015 Nov; 14():149. PubMed ID: 26553117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic administration of an endothelin-A receptor antagonist improves exercise capacity in rats with myocardial infarction-induced congestive heart failure.
    Miyauchi T; Fujimori A; Maeda S; Iemitsu M; Sakai S; Shikama H; Tanabe T; Matsuda M; Goto K; Yamaguchi I
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S64-7. PubMed ID: 15838361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of diabetes mellitus, pressure-overload and their association on myocardial structure and function.
    Falcão-Pires I; Gonçalves N; Moura C; Lamego I; Eloy C; Lopes JM; Begieneman MP; Niessen HW; Areias JC; Leite-Moreira AF
    Am J Hypertens; 2009 Nov; 22(11):1190-8. PubMed ID: 19745820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrauterine growth restriction coupled with hyperglycemia: effects on cardiac structure in adult rats.
    Lim K; Lombardo P; Schneider-Kolsky M; Black MJ
    Pediatr Res; 2012 Oct; 72(4):344-51. PubMed ID: 22797140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble guanylyl cyclase activation improves progressive cardiac remodeling and failure after myocardial infarction. Cardioprotection over ACE inhibition.
    Fraccarollo D; Galuppo P; Motschenbacher S; Ruetten H; Schäfer A; Bauersachs J
    Basic Res Cardiol; 2014 Jul; 109(4):421. PubMed ID: 24907870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.
    Poulsen SH
    Dan Med Bull; 2001 Nov; 48(4):199-210. PubMed ID: 11767125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DPP-4 inhibition attenuates cardiac dysfunction and adverse remodeling following myocardial infarction in rats with experimental diabetes.
    Connelly KA; Zhang Y; Advani A; Advani SL; Thai K; Yuen DA; Gilbert RE
    Cardiovasc Ther; 2013 Oct; 31(5):259-67. PubMed ID: 22963483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of Trimetazidine upon ventricular remodeling and GLUT4 in diabetic rats after myocardial infarction].
    Zhang RY; Yu P; Wang F; Shen JX; Wang YM
    Zhonghua Yi Xue Za Zhi; 2009 May; 89(18):1240-5. PubMed ID: 19595176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Streptozotocin-induced hyperglycemia exacerbates left ventricular remodeling and failure after experimental myocardial infarction.
    Shiomi T; Tsutsui H; Ikeuchi M; Matsusaka H; Hayashidani S; Suematsu N; Wen J; Kubota T; Takeshita A
    J Am Coll Cardiol; 2003 Jul; 42(1):165-72. PubMed ID: 12849678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiplatelet therapy mitigates cardiac remodeling and dysfunction in congestive heart failure due to myocardial infarction.
    Sanganalmath SK; Barta J; Takeda N; Kumamoto H; Dhalla NS
    Can J Physiol Pharmacol; 2008 Apr; 86(4):180-9. PubMed ID: 18418427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of diabetes on postinfarction heart failure and left ventricular remodeling.
    von Bibra H; St John Sutton M
    Curr Heart Fail Rep; 2011 Dec; 8(4):242-51. PubMed ID: 21842146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic vasopressin V(1A) but not V(2) receptor antagonism prevents heart failure in chronically infarcted rats.
    Van Kerckhoven R; Lankhuizen I; van Veghel R; Saxena PR; Schoemaker RG
    Eur J Pharmacol; 2002 Aug; 449(1-2):135-41. PubMed ID: 12163117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.